CALANDRA BUONAURA, Sebastiano
 Distribuzione geografica
Continente #
NA - Nord America 17.260
AS - Asia 8.418
EU - Europa 7.289
SA - Sud America 1.253
AF - Africa 174
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 13
Totale 34.420
Nazione #
US - Stati Uniti d'America 17.028
SG - Singapore 3.206
GB - Regno Unito 2.552
CN - Cina 2.152
IT - Italia 1.408
HK - Hong Kong 970
BR - Brasile 963
VN - Vietnam 819
SE - Svezia 773
DE - Germania 560
FI - Finlandia 371
FR - Francia 346
UA - Ucraina 341
RU - Federazione Russa 329
KR - Corea 220
TR - Turchia 215
IN - India 201
BG - Bulgaria 141
ID - Indonesia 114
NL - Olanda 108
AR - Argentina 94
BD - Bangladesh 88
CA - Canada 86
MX - Messico 82
IE - Irlanda 70
IQ - Iraq 68
JP - Giappone 53
BE - Belgio 51
ZA - Sudafrica 50
PK - Pakistan 49
PL - Polonia 46
EC - Ecuador 41
AE - Emirati Arabi Uniti 39
CO - Colombia 38
CL - Cile 37
ES - Italia 36
AT - Austria 26
CZ - Repubblica Ceca 26
SA - Arabia Saudita 23
KE - Kenya 22
VE - Venezuela 21
EG - Egitto 20
MA - Marocco 20
TN - Tunisia 20
UZ - Uzbekistan 20
PY - Paraguay 18
BZ - Belize 17
CH - Svizzera 17
DZ - Algeria 17
IR - Iran 17
LT - Lituania 16
MY - Malesia 16
PE - Perù 16
UY - Uruguay 16
JO - Giordania 14
PH - Filippine 13
TW - Taiwan 12
AU - Australia 11
OM - Oman 11
PT - Portogallo 11
AZ - Azerbaigian 10
BA - Bosnia-Erzegovina 10
KZ - Kazakistan 10
NP - Nepal 10
RO - Romania 9
TH - Thailandia 9
BH - Bahrain 8
BO - Bolivia 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
EU - Europa 8
IL - Israele 8
AL - Albania 6
ET - Etiopia 6
JM - Giamaica 6
KG - Kirghizistan 6
KW - Kuwait 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
HU - Ungheria 5
LB - Libano 5
SK - Slovacchia (Repubblica Slovacca) 5
GR - Grecia 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
LK - Sri Lanka 3
NG - Nigeria 3
PR - Porto Rico 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SN - Senegal 3
AO - Angola 2
BY - Bielorussia 2
CG - Congo 2
Totale 34.381
Città #
Singapore 2.106
Southend 1.865
Fairfield 1.752
Ashburn 1.747
Santa Clara 1.595
Woodbridge 1.212
Houston 1.002
Hong Kong 952
San Jose 788
Hefei 769
Chandler 751
Jacksonville 744
Seattle 697
Wilmington 615
Ann Arbor 610
Cambridge 560
Nyköping 458
Dearborn 445
London 372
Beijing 327
Ho Chi Minh City 271
Helsinki 253
Los Angeles 231
Seoul 217
The Dalles 216
Modena 208
Hanoi 192
Chicago 188
Milan 174
San Diego 152
New York 150
Council Bluffs 149
Princeton 148
Sofia 134
Lauterbourg 118
Eugene 115
Moscow 104
Rome 99
Buffalo 96
Shanghai 94
Des Moines 89
São Paulo 89
Izmir 88
Grafing 82
Columbus 80
Dallas 80
Salt Lake City 79
Jakarta 78
Dublin 68
Munich 59
Da Nang 56
Orem 53
Falls Church 49
Rio de Janeiro 44
Naples 43
Brussels 41
Tokyo 41
Bremen 38
Elk Grove Village 38
Atlanta 37
Boardman 37
Tampa 37
Frankfurt am Main 33
Warsaw 33
Bologna 32
Mexico City 28
Redwood City 28
Belo Horizonte 27
Norwalk 27
Guangzhou 26
Nuremberg 26
Brooklyn 25
Chennai 25
Santiago 25
Toronto 24
Baghdad 23
Nanjing 23
Haiphong 22
Johannesburg 22
Montreal 22
San Mateo 22
Turin 22
Brno 20
Kent 20
Detroit 19
Manchester 19
Poplar 19
San Francisco 19
Boston 18
Kunming 18
St Louis 18
Tashkent 18
Amsterdam 17
Augusta 17
Belize City 17
Biên Hòa 17
Brasília 17
Nairobi 17
Phoenix 16
Can Tho 15
Totale 24.818
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.148
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 524
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease 405
A 'de novo' point mutation of the low-density lipoprotein receptor gene in an Italian subject with primary hypercholesterolemia 374
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 364
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 363
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 362
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region 351
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 349
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 344
Altered mRNA splicing in lipoprotein disorders 341
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 340
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy 338
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 335
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 329
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 325
An apparent inconsistency in parent to offspring transmission ofpoint mutations of LDLR gene in familial hypercholesterolemia 323
Adaptor protein ARH is recruited to the plasma membrane by low density lipoprotein (LDL) binding and modulates endocytosis of the LDL/LDL receptor complex in hepatocytes 321
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 320
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 317
MOLECULAR CHARACTERIZATION OF TWO PATIENTS WITH SEVERE LCAT DEFICIENCY 314
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 313
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 312
Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol. 310
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 309
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 307
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 303
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 295
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients 293
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 292
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 291
Denaturing high-performance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency 288
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 288
Preemptive liver transplantation in a child with familial hypercholesterolemia 287
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 282
Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. 280
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 280
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 278
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 277
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 275
Rearrangements of the ABCC6 gene in Italian patients with PXE 274
Functional lecithin: Cholesterol acyltransferase Is not required for efficient atheroprotection in humans 274
Severe HDL deficiency due to novel defects in the ABCA1 transporter 272
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 272
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 271
A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 270
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 270
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 269
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 266
Effect of the desulfation of heparin on its anticoagulant and anti-proliferative activity 264
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 264
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 262
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 262
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 259
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): A phenotypic comparison 259
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 258
A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene 258
Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia 254
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia 252
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 252
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 251
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 251
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 251
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 250
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia 248
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 245
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 245
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 245
Changes of the main isoform of human apolipoprotein A-I following incubation of plasma. 240
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 237
Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia. 236
Pravastatin in heterozygous familial hypercholesterolemia: low-density lipoprotein (LDL) cholesterol-lowering effect and LDL receptor activity on skin fibroblastS. 236
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 236
Plasma lipoproteins in rats with experimental biliary obstruction. II. An ultrastructural study. 235
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 233
A large deletion in the LDL receptor gene--the cause of familial hypercholesterolemia in three Italian families: a study that dates back to the 17th century (FH-Pavia 233
Partial duplication of the EGF precursor homology domain of the LDL receptor protein causing familial hypercholesterolemia (FH-Salerno) 233
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 231
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 230
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 228
Duplication of exons 13, 14 and 15 of the LDL-receptor gene in a patients with heterozygous familial hypercholesterolemia 228
Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. 225
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene 221
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 217
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 217
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins. 217
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 216
Synthesis and secretion of apolipoprotein A-I by chick skin. 216
Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. 216
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 215
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). 214
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 214
Cholesterol synthesis in freshly isolated human leukocytes. 211
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 211
Severe hypertriglyceridemia in a newborn with monogenic lipoprotein lipase deficiency: an unconventional therapeutic approach with exchange transfusion. 210
Plasma lipoproteins in rats with experimental biliary obstruction. I. A chemical study. 206
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. 204
Plasma lecithin: cholesterol acyltransferase activity in liver disease. 203
A man with low cholesterol and weakness of the lower limbs. 201
Trascriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator activated receptor, and liver X receptor signaling in macrophages 200
Totale 28.085
Categoria #
all - tutte 129.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 0 0 0 0 0 257 150
2021/20222.677 109 307 317 155 55 210 204 103 284 178 494 261
2022/20232.390 258 267 163 197 285 383 37 213 324 53 99 111
2023/20241.564 66 78 144 141 292 162 150 162 56 90 40 183
2024/20256.147 196 52 118 406 1.129 968 592 340 534 191 712 909
2025/202610.643 788 548 973 1.144 1.925 810 1.520 595 993 1.195 152 0
Totale 34.573